NYU Langone Health Cardiac Amyloidosis Diagnosis and Novel Therapeutics in 2024

Name: NYU Langone Health Cardiac Amyloidosis Diagnosis and Novel Therapeutics in 2024 - DrMedciene
SKU: MED-AMB-00812
Price: 20.00 USD
Availability: InStock

$20.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Include: 1 video + 17 pdfs, size: 13.5 GB

SKU: MED-AMB-00812 Categories: Cardiology, Internal Medicine Tags: CARDIOLOGY, Internal Medicine

Description

NYU Langone Health Cardiac Amyloidosis Diagnosis and Novel Therapeutics in 2024

Include: 1 video + 17 pdfs, size: 13.5 GB

Target Audience: cardiologists, internists

Information:

NYU Langone Health, 550 First Ave New York, NY United States
September 19, 2024 8:00 AM – 5:30 PM

This is a live and virtual course designed for cardiologists, internists, nurse practitioners, nurses, physician assistants, and anyone who cares for patients with different types of amyloidosis. The majority of the speakers form part of our multidisciplinary amyloidosis team. There will be an emphasis on cardiac manifestations of amyloidosis, and experts in the fields of cardiac imaging, electrophysiology, and advanced heart failure and transplantation will discuss new diagnostic and therapeutic options. There will also be educational sessions on the neurologic, gastrointestinal, renal, and musculoskeletal manifestations of amyloidosis. Our experts in the AL Amyloidosis and Multiple Myeloma Program will provide an update on AL amyloidosis and ongoing clinical trials.

Educational Objectives

After participating in this activity, clinicians should be able to:

Explain the advantages and disadvantages of different imaging techniques that can be used in the diagnosis and monitoring of cardiac amyloidosis
Describe treatment options under investigation for amyloidosis
Recognize potential barriers and learn about the process on creating an amyloidosis program/clinic
Identify patients who would benefit from advanced heart failure therapies including heart transplantation
Describe new treatment (e.g., pacing) strategies in patients with conduction system disease and atrial/ventricular arrhythmias
Recognize the clinical contributions from different sub-specialists when caring for these patients
Develop a mechanism to identify patients with advanced amyloidosis who could benefit from clinical trials and advanced therapeutics
Diagnose the type of amyloidosis and implement a treatment strategy

Target Audience

Any healthcare provider who cares for patients with amyloidosis. This includes physicians, nurse practitioners, nurses, physician assistants, medical students, and residents/fellows who specialize in Neurology, Gastroenterology, Hand Surgery, Hematology and Oncology.

Topics:

Agenda.pdf
Advances in Positron Emission Tomography (PET) and Amyloidosis.pdf
AL (Light Chain) Amyloidosis Non-Transplant Treatment.pdf
AL (Light Chain) Amyloidosis Pathogenesis and Diagnosis.pdf
Cardiac Electrophysiology and Amyloidosis.pdf
Cardiac Imaging Echocardiography.pdf
Cardiac Imaging Nuclear Imaging Modalities.pdf
Creating and Developing an Amyloidosis Clinic.pdf
Gastrointestinal Manifestations of Amyloidosis.pdf
Neurological Manifestations of Amyloidosis.pdf
New and Ongoing Clinical Trials in Amyloidosis NYULH Experience 1.pdf
New and Ongoing Clinical Trials in Amyloidosis NYULH Experience 2.pdf
Orthopedic and Musculoskeletal Manifestations of Amyloidosis.pdf
Renal Manifestations of Amyloidosis.pdf
Role of Cardiac Magnetic Resonance Imaging (MRI) in Amyloidosis.pdf
The Future of Amyloidosis Treatment Gene Editing and Antibody Therapy.pdf
Transthyretin Amyloidosis Emphasis on Cardiomyopathy.pdf
September 19.mp4 (8 hours 48 minutes)